Sarepta Therapeutics Ownership | Who Owns Sarepta Therapeutics?


OverviewForecastRevenueFinancialsChartTranscripts

Sarepta Therapeutics Ownership Summary


Sarepta Therapeutics is owned by 43.18% institutional investors, 4.66% insiders, and 52.16% retail investors. Tudor investment corp et al is the largest institutional shareholder, holding 70.23% of SRPT shares. iShares Core S&P Small-Cap ETF is the top mutual fund, with 5.57% of its assets in Sarepta Therapeutics shares.

SRPT Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockSarepta Therapeutics43.18%4.66%52.16%
SectorHealthcare Stocks 42.54%10.83%46.63%
IndustryBiotech Stocks 45.22%10.75%44.04%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Tudor investment corp et al68.83M70.23%$63.35M
Blackrock funding, inc. /de13.20M13.47%$254.36M
Vanguard group10.82M11.04%$208.45M
Blackrock10.32M10.98%$1.63B
State street5.30M5.41%$102.23M
Janus henderson group4.33M4.54%$526.20M
Erste asset management gmbh2.69M2.74%$50.59M
Renaissance2.65M2.70%$51.07M
Two sigma investments, lp2.14M2.18%$41.19M
Ubs group1.99M2.03%$38.36M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Boxer capital650.00K5.41%$102.70M
Ghost tree capital55.00K2.72%$8.69M
Bioimpact capital700.00K2.21%$13.49M
Opaleye management585.00K1.59%$11.27M
Boxer capital management250.00K1.54%$4.82M
683 capital management990.00K1.00%$19.08M
Union square park capital management105.00K0.72%$2.02M
Adar1 capital management349.81K0.63%$6.74M
Corton capital12.02K0.57%$231.63K
Quinn opportunity partners376.24K0.51%$7.25M

Top Buyers

HolderShares% AssetsChange
Tudor investment corp et al68.83M0.11%68.78M
Blackrock10.32M0.04%4.36M
Renaissance2.65M0.07%2.03M
Vanguard group10.82M0.00%1.66M
Ubs group1.99M0.01%1.49M

Top Sellers

HolderShares% AssetsChange
Avoro capital advisors---2.67M
Wellington management group llp---2.53M
Farallon capital management---2.34M
Exome asset management---2.00M
Qube research---1.60M

New Positions

HolderShares% AssetsChangeValue
Norges bank1.04M0.02%1.04M$126.32M
Public sector pension investment board381.17K0.03%381.17K$7.35M
Silver point capital278.28K0.28%278.28K$5.36M
Union square park capital management105.00K0.72%105.00K$2.02M
Nebula research & development98.08K0.14%98.08K$1.68M

Sold Out

HolderChange
Bokf, na-1.00
Harbor investment advisory-1.00
Twin peaks wealth advisors-1.00
Financial gravity asset management-1.00
Hfm investment advisors-1.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 2025163-60.63%42,318,819-50.10%430.58%77-65.47%57-36.67%
Jun 30, 2025410-12.02%84,724,983-2.96%861.07%2222.30%89-42.58%
Mar 31, 202523-95.40%6,342,126-92.89%60.07%12-95.02%7-95.39%
Dec 31, 2024187-62.75%19,880,204-77.21%200.25%88-61.40%54-65.82%
Sep 30, 2024498-6.57%87,082,917-1.33%911.04%226-23.65%15718.05%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
iShares Core S&P Small-Cap ETF5.83M5.57%-
iShares Core S&P Mid-Cap ETF3.20M3.28%-5.78K
American Funds Growth Fund of Amer A3.15M3.25%-5.26K
Capital Group Growth Fnd of Amer Comp3.15M3.21%-5.26K
Vanguard Total Stock Mkt Idx Inv2.96M3.03%-62.10K
Vanguard US Total Market Shares ETF2.85M2.94%2.16K
American Funds AMCAP A2.66M2.74%133.61K
Capital Group AMCAP Composite2.66M2.71%133.61K
VA CollegeAmerica Amcap 529A2.52M2.64%425.56K
Vanguard Small Cap Index2.27M2.32%-6.75K

Recent Insider Transactions


DateNameRoleActivityValue
Mar 12, 2025Nicaise Claude-Sell$248.20K
Dec 12, 2024Wigzell Hans Lennart Rudolf-Sell$1.31M
Dec 05, 2024Boor Kathryn Jean-Sell$205.40K
Aug 30, 2024Estepan Ian Michael Chief Financial OfficerSell$822.10K
Aug 16, 2024Chambers Michael Andrew-Buy$2.45M

Insider Transactions Trends


DateBuySell
2026 Q1--
2025 Q3--
2025 Q2--
2025 Q1-1
2024 Q331

SRPT Ownership FAQ


Who Owns Sarepta Therapeutics?

Sarepta Therapeutics shareholders are primarily institutional investors at 43.18%, followed by 4.66% insiders and 52.16% retail investors. The average institutional ownership in Sarepta Therapeutics's industry, Biotech Stocks , is 45.22%, which Sarepta Therapeutics falls below.

Who owns the most shares of Sarepta Therapeutics?

Sarepta Therapeutics’s largest shareholders are Tudor investment corp et al (68.83M shares, 70.23%), Blackrock funding, inc. /de (13.2M shares, 13.47%), and Vanguard group (10.82M shares, 11.04%). Together, they hold 94.74% of Sarepta Therapeutics’s total shares outstanding.

Does Blackrock own Sarepta Therapeutics?

Yes, BlackRock owns 10.98% of Sarepta Therapeutics, totaling 10.32M shares as of Jun 2024. This represents 0.04% of BlackRock's total assets, with a market value of 1.63B$. In the last quarter, BlackRock increased its holdings by 4.36M shares, a 73.22% change.

Who is Sarepta Therapeutics’s biggest shareholder by percentage of total assets invested?

Boxer capital is Sarepta Therapeutics’s biggest shareholder by percentage of total assets invested, with 5.41% of its assets in 650K Sarepta Therapeutics shares, valued at 102.7M$.

Who is the top mutual fund holder of Sarepta Therapeutics shares?

iShares Core S&P Small-Cap ETF is the top mutual fund holder of Sarepta Therapeutics shares, with 5.57% of its total shares outstanding invested in 5.83M Sarepta Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools